Svensk Kirurgi nr 5-20

244 SVENSK KIRURGI • VOLYM 78 • NR 5 • 2020 Referenser 1. Fleming CR, Remington M. Intestinal Failure. In: Hill GL, ed. Nutrition and the Surgical Patient. Churchill Livingstone; 1981:219–235. 2. Pironi L, Arends J, Baxter J, et al. ESPEN endorsed recommendations. Definition and classification of intestinal failure in adults. Clin Nutrition Edinb Scotl. 2014;34:171–80. 3. Shaffer J. Definition and service develop- ment. Clin Nutr. 2002;21:144–145. 4. Bemelman WA, Warusavitarne J, Sampi- etro GM, et al. ECCO-ESCP Consensus on Surgery for Crohn’s Disease. J Crohn’s Colitis. 2017;12:1–16. 5. Lamb CA, Kennedy NA, Raine T, et al. British Society of Gastroenterology con- sensus guidelines on the management of inflammatory bowel disease in adults. Gut. 2019;68:s1–s106. 6. Nguyen GC, Loftus EV, Hirano I, et al. American Gastroenterological Association Institute Guideline on the Management of Crohn’s Disease After Surgical Resection. Gastroenterology. 2016;152:271–275. 7. Bellolio F, Cohen Z, MacRae HM, et al. Strictureplasty in Selected Crohn’s Disease Patients Results in Acceptable Long-term Outcome. Dis Colon Rectum. 2012;55:864–869. 8. Mege D, Michelassi F. Michelassi II Stric- tureplasty for Crohnʼs Disease: A New Side-to-Side Isoperistaltic Strictureplasty With Discontinuous Bowel Loops. Ann Surg. 2020;271:e1–e2. 9. Soop M. Challenges in Crohn’s Disease: Intestinal Failure and Short Bowel Syn- drome in Crohn’s Disease. Seminars Colon Rectal Surg. 2020;31:100749. 10. Dibb M, Soop M, Teubner A, et al. Survi- val and nutritional dependence on home parenteral nutrition: Three decades of experience from a single referral centre. Clin Nutr. 2017;36:570–576. 11. LLOYD DAJ, VEGA R, BASSETT P, et al. Survival and dependence on home paren- teral nutrition: experience over a 25-year period in a UK referral centre. Alimentary Pharmacol Ther. 2006;24:1231–1240. 12. Watanabe K, Sasaki I, Fukushima K, et al. Long-term incidence and characteristics of intestinal failure in Crohn’s disease: a multicenter study. J Gastroenterol. 2013;49:231–8. 13. Watanabe Y, Miyoshi N, Fujino S, et al. Cumulative Inflammation Could Be a Risk Factor for Intestinal Failure in Crohn’s Disease. Digest Dis Sci. 2019;64:2280–2285. 14. Gearry RB, Kamm MA, Hart AL, et al. Predictors for developing intestinal failure in patients with Crohn’s disease. J Gastroen Hepatol. 2013;28:801–807. 15. Elriz K, Palascak‐Juif V, Joly F, et al. Crohn’s disease patients with chronic intestinal failure receiving long‐term paren- teral nutrition: a cross‐national adult study. Aliment Pharm Therap. 2011;34:931–940. 16. Uchino M, Ikeuchi H, Bando T, et al. Risk factors for short bowel syndrome in patients with Crohn’s disease. Surg Today. 2012;42:447–452. 17. Gustavsson A, Magnuson A, Blomberg B, et al. Endoscopic dilation is an efficacious and safe treatment of intestinal strictures in Crohn’s disease. Aliment Pharm Therap. 2012;36:151–8. 18. Soop M, Khan H, Nixon E, et al. Causes and Prognosis of Intestinal Failure in Crohn’s Disease: An 18-year Experience From a National Centre. J Crohn’s Colitis. . Epub ahead of print 2020. DOI: 10.1093/ ecco-jcc/jjaa060. 19. Nguyen DL, Sandborn WJ, Loftus EV, et al. Similar Outcomes of Surgical and Medi- cal Treatment of Intra-abdominal Abscesses in Patients With Crohn’s Disease. Clin Gastroenterol H. 2012;10:400–404. 20. Feagins LA, Holubar SD, Kane SV, et al. Current Strategies in the Manage- ment of Intra-abdominal Abscesses in Crohn’s Disease. Clin Gastroenterol H. 2011;9:842–850. 21. group 2015 European Society of Coloproc- tology collaborating. Risk factors for unfa- vourable postoperative outcome in patients with Crohn’s disease undergoing right hemicolectomy or ileocaecal resection An international audit by ESCP and S-ECCO. Colorectal Dis Official J Assoc Coloprocto- logy Gt Br Irel. 2017;20:219–227. 22. Fumery M, Seksik P, Auzolle C, et al. Postoperative Complications after Ileocecal Resection in Crohn’s Disease: A Prospective Study From the REMIND Group. Am J Gastroenterol. 2017;112:337–345. 23. Galata C, Kienle P, Weiss C, et al. Risk fac- tors for early postoperative complications in patients with Crohn’s disease after colo- rectal surgery other than ileocecal resection or right hemicolectomy. Int J Colorectal Dis. 2018;34:293–300. 24. Tzivanakis A, Singh JC, Guy RJ, et al. Influ- ence of Risk Factors on the Safety of Ileoco- lic Anastomosis in Crohn’s Disease Surgery. Dis Colon Rectum. 2012;55:558–562. 25. Alves A, Panis Y, Bouhnik Y, et al. Risk Factors for Intra‐Abdominal Septic Complications After a First Ileocecal Resec- tion for Crohn’s Disease: A Multiva- riate Analysis in 161 Consecutive Patients. Dis Colon Rectum. 2007;50:331–336. 26. Brouquet A, Maggiori L, Zerbib P, et al. Anti-TNF Therapy Is Associated With an Increased Risk of Postoperative Morbidity After Surgery for Ileocolonic Crohn Disease: Results of a Prospective Nationwide Cohort. Ann Surg. 2018;267:221–228. 27. Lin Y-S, Cheng S-W, Wang Y-H, et al. Systematic review with meta-analysis: risk of post-operative complications associated with pre-operative exposure to anti-tumour necrosis factor agents for Crohn’s disease. Aliment Pharm Therap. 2019;49:966–977. 28. Patel KV, Darakhshan AA, Griffin N, et al. Patient optimization for surgery relating to Crohn’s disease. Nat Rev Gastroentero. 2016;13:707–719. 29. Grass F, Pache B, Martin D, et al. Pre- operative Nutritional Conditioning of Crohn’s Patients—Systematic Review of Current Evidence and Practice. Nutrients. 2017;9:562. 30. Candido FD, Moggia E, Spinelli A. Pre-operative optimisation in Crohn’s Disease. Seminars Colon Rectal Surg. 2020;31:100742. 31. Ge X, Tang S, Yang X, et al. The role of exclusive enteral nutrition in the pre- operative optimization of laparoscopic surgery for patients with Crohn’s disease: a cohort study. Int J Surg Lond Engl. 2019;65:39–44. 32. Heerasing N, Thompson B, Hendy P, et al. Exclusive enteral nutrition provides an effective bridge to safer interval elective surgery for adults with Crohn’s disease. Aliment Pharm Therap. 2017;45:660–669. 33. Li Y, Zuo L, Zhu W, et al. Role of Exclusive Enteral Nutrition in the Preoperative Opti- mization of Patients With Crohn’s Disease Following Immunosuppressive Therapy. Medicine. 2015;94:e478. 34. Myrelid P, Söderholm JD, Olaison G, et al. Split stoma in resectional surgery of high-risk patients with ileocolonic Crohn’s disease: Split stoma in resectional surgery. Colorectal Dis. 2012;14:188–193. 35. Williams NMA, Scott NA, Irving MH. Successful management of external duode- nal fistula in a specialized unit. Am J Surg. 1997;173:240–241. 36. Lambe G, Russell C, West C, et al. Auto- logous reconstruction of massive entero- atmospheric fistulation with a pedicled subtotal lateral thigh flap. Br J Surg. 2012;99:964–72. 37. Visschers RGJ, Damink SWMO, Win- kens B, et al. Treatment Strategies in 135 Consecutive Patients with Enterocutaneous Fistulas. World J Surg. 2008;32:445–453. 38. Martinez JL, Luque-de-Leon E, Mier J, et al. Systematic Management of Postope- rative Enterocutaneous Fistulas: Factors Related to Outcomes. World J Surg. 2007;32:436–443. 39. STREAT SJ, BEDDOE AH, HILL GL. Aggressive Nutritional Support Does Not Prevent Protein Loss Despite Fat Gain in Septic Intensive Care Patients. J Trauma Inj Infect Critical Care. 1987;27:262–266. 40. Lynch AC, Delaney CP, Senagore AJ, et al. Clinical Outcome and Factors Predictive of Recurrence After Enterocutaneous Fistula Surgery. Ann Surg. 2004;240:825–831. 41. Bond A, Teubner A, Taylor M, et al. Asses- sing the impact of quality improvement measures on catheter related blood stream infections and catheter salvage: Experience from a national intestinal failure unit. Clin Nutr. 2018;37:2097–2101. 42. Pironi L, Arends J, Bozzetti F, et al. ESPEN guidelines on chronic intestinal failure in adults. Clin Nutr. 2016;35:247–307. 43. Nightingale JMD. The medical mana- gement of intestinal failure: methods to reduce the severity. P Nutr Soc. 2003;62:703–710. 44. Rosen MJ, Bauer JJ, Harmaty M, et al. Multicenter, Prospective, Longitudinal Study of the Recurrence, Surgical Site Infection, and Quality of Life After Conta- minated Ventral Hernia Repair Using Bio- synthetic Absorbable Mesh: The COBRA Study. Ann Surg. 2017;265:205–211. 45. Rutter CS, Amin I, Russell NK, et al. Adult Intestinal and Multivisceral Transplanta- tion: Experience From a Single Center in the United Kingdom. Transplant P. 2016;48:468–472. 46. Bianchi A. Intestinal loop lengthening—A technique for increasing small intestinal length. J Pediatr Surg. 1980;15:145–151. 47. Kim HB, Lee PW, Garza J, et al. Serial transverse enteroplasty for short bowel syndrome: a case report. J Pediatr Surg. 2003;38:881–885. 48. Jeppesen PB, Gilroy R, Pertkiewicz M, et al. Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndrome. Gut. 2011;60:902–14. 49. Kochar B, Long MD, Shelton E, et al. Safety and Efficacy of Teduglutide (Gattex) in Patients With Crohn’s Disease and Need for Parenteral Support Due to Short Bowel Syndrome–associated Intestinal Failure. J Clin Gastroenterol. 2017;51:508–511. Översiktsartikel